Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01205724
What this trial is testing

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 27
Testing effectiveness (Phase 2)Study completedNCT00640523
What this trial is testing

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
BioCryst Pharmaceuticals 23
Testing effectiveness (Phase 2)Study completedNCT02221479
What this trial is testing

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 14
Large-scale testing (Phase 3)Study completedNCT01015196
What this trial is testing

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Nantes University Hospital 832
Early research (Phase 1)Looking for participantsNCT05709288
What this trial is testing

Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 9
Testing effectiveness (Phase 2)Ended earlyNCT01058369
What this trial is testing

Exjade-Early-Trial

Who this might be right for
Myelodysplastic Syndromes
University of Erlangen-Nürnberg Medical School 2
Early research (Phase 1)Active Not RecruitingNCT05552469
What this trial is testing

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Who this might be right for
Myeloid Diseases
Novartis Pharmaceuticals 71
Not applicableUnknownNCT00856076
What this trial is testing

Venous Thromboembolism in Pregnancy Study

Who this might be right for
Venous ThromboembolismIntrauterine Fetal Death
Oslo University Hospital 1,200
Large-scale testing (Phase 3)Ended earlyNCT00500240
What this trial is testing

Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 52
Post-approval studies (Phase 4)UnknownNCT02760940
What this trial is testing

Anemia in Inflammatory Bowel Disease

Who this might be right for
AnemiaBowel Diseases, Inflammatory
Federal University of Juiz de Fora 200
Not applicableLooking for participantsNCT06710418
What this trial is testing

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more
University of Washington 50
Early research (Phase 1)Study completedNCT01410513
What this trial is testing

Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin LymphomaMantle Cell LymphomaChronic Lymphocytic Leukemia
Sanofi 37
Not applicableLooking for participantsNCT06229860
What this trial is testing

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid LeukemiaChronic Phase Chronic Myelogenous Leukemia
University of California, Irvine 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02846623
What this trial is testing

Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome

Who this might be right for
Chronic Lymphocytic LeukemiaRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic Leukemia+2 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02044796
What this trial is testing

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+3 more
Fred Hutchinson Cancer Center 199
Large-scale testing (Phase 3)Study completedNCT03329196
What this trial is testing

Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

Who this might be right for
Anemia; Non-dialysis Dependent Chronic Kidney Disease
Tanabe Pharma Corporation 304
Not applicableStudy completedNCT01041846
What this trial is testing

Dacogen Treatment in Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Janssen Korea, Ltd., Korea 103
Testing effectiveness (Phase 2)WithdrawnNCT01269203
What this trial is testing

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Not applicableNot Yet RecruitingNCT07828327
What this trial is testing

Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma

Who this might be right for
Allergic Bronchopulmonary AspergillosisABPASevere Eosinophilic Asthma
Qianfoshan Hospital 10
Large-scale testing (Phase 3)UnknownNCT02611973
What this trial is testing

Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia

Who this might be right for
MPNEssential Thrombocythemia
Assistance Publique - Hôpitaux de Paris 2,250
Next Page